Literature DB >> 24337532

Preoperative factors associated with red blood cell transfusion in hip fracture patients.

Christian Medom Madsen1, Henrik Løvendahl Jørgensen, Astrid Norgaard, Troels Riis, Christopher Jantzen, Ole Birger Pedersen, Benn Rønnow Duus, Jes Bruun Lauritzen.   

Abstract

INTRODUCTION: Red blood cell (RBC) transfusion is a frequently used treatment in patients admitted with a fractured hip, but the use remains an area of much debate. The aim of this study was to determine preoperative factors associated with the risk of receiving a red blood cell transfusion in hip fracture patients.
METHOD: The study included 986 consecutive hip fracture patients (aged 60 years or above). The patients were identified from a database of all hip fracture patients admitted to Bispebjerg University Hospital. Data for the database are collected via chart review and data extraction from the hospitals laboratory system, public registries and from the Capital Region Blood Bank Database.
RESULTS: Overall transfusion rate was 58.7 %. The univariate analyses showed that transfusion rate was higher among women (p = 0.004), older patients (p < 0.0001), patients with high ASA scores (p < 0.0001), patients with more severe fractures (p < 0.0001), patients with lower admission haemoglobin levels (p < 0.0001), patients not admitted from own home (p = 0.02) and patients taking aspirin (p = 0.007) or other platelet inhibitors (p = 0.01) on admission. In the multivariate analysis, increasing age, ASA ≥3, being admitted from own home, extracapsular fractures, decreasing admission haemoglobin and use of platelet inhibitors were all significantly associated with the risk of receiving a RBC transfusion.
CONCLUSION: Several readily available preoperative factors in the form of age, residence, ASA, admission haemoglobin, medication and type of fracture were independently associated with the likelihood of receiving a red blood cell transfusion in patients admitted with a fractured hip.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337532     DOI: 10.1007/s00402-013-1906-3

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  14 in total

1.  Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery.

Authors:  A B Pedersen; D Cronin Fenton; M Nørgaard; N R Kristensen; B Kuno Møller; C Erikstrup
Journal:  Osteoporos Int       Date:  2016-04-21       Impact factor: 4.507

2.  Preoperative antithrombotic therapy and risk of blood transfusion and mortality following hip fracture surgery: a Danish nationwide cohort study.

Authors:  C Daugaard; A B Pedersen; N R Kristensen; S P Johnsen
Journal:  Osteoporos Int       Date:  2018-11-29       Impact factor: 4.507

Review 3.  The Perioperative Management of Antiplatelet and Anticoagulant Drugs in Hip Fractures: Do the Surgery as Early as Possible.

Authors:  Mohammad Ali Ghasemi; Ehsan Ghadimi; Ahmad Shamabadi; Sm Javad Mortazavi
Journal:  Arch Bone Jt Surg       Date:  2022-06

4.  Differences in total blood loss and transfusion rate between different indications for shoulder arthroplasty.

Authors:  Dominik Malcherczyk; Juliane Hack; Antonio Klasan; Asma Abdelmoula; Thomas J Heyse; Brandon Greene; Bilal F El-Zayat
Journal:  Int Orthop       Date:  2018-08-03       Impact factor: 3.075

5.  Reducing unnecessary crossmatching for hip fracture patients by accounting for preoperative hemoglobin concentration.

Authors:  Raj M Amin; Varun Puvanesarajah; Yash P Chaudhry; Matthew J Best; Sandesh S Rao; Steven M Frank; Erik A Hasenboehler
Journal:  World J Orthop       Date:  2021-05-18

6.  Risk factors for the effect of anticoagulant and antiplatelet agents on perioperative blood loss following proximal femoral fractures.

Authors:  Yusuke Akaoka; Hiroshi Yamazaki; Hiroyuki Kodaira; Hiroyuki Kato
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  "Hidden" Preoperative Blood Loss With Extracapsular Versus Intracapsular Hip Fractures: What Is the Difference?

Authors:  Katharine D Harper; Paul Navo; Frederick Ramsey; Sainabou Jallow; Saqib Rehman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2017-11-22

8.  Development and validation of a nomogram to predict perioperative blood transfusion in patients undergoing total knee arthroplasty.

Authors:  Chuan Hu; Yuan-He Wang; Rui Shen; Chuan Liu; Kang Sun; Lin Ye; Jian-Jun Ye; Xu Yang; Shao-Qi Tian; Teng-Bo Yu
Journal:  BMC Musculoskelet Disord       Date:  2020-05-20       Impact factor: 2.362

9.  Introduction of national guidelines for restrictive blood transfusion threshold for hip fracture patients--a consecutive cohort study based on complete follow-up in national databases.

Authors:  Bjarke Viberg; Per Hviid Gundtoft; Jesper Schønnemann; Lasse Pedersen; Lis Røhl Andersen; Kjell Titlestad; Carsten Fladmose Madsen; Jens Lauritsen; Søren Overgaard
Journal:  J Orthop Surg Res       Date:  2018-05-18       Impact factor: 2.359

10.  Risk factors of perioperative blood transfusion in elderly patients with femoral intertrochanteric fracture.

Authors:  Cheng-Qian Dai; Li-Hong Wang; Ye-Qin Zhu; Guo-Hong Xu; Jun-Biao Shan; Wei-Chun Huang; Li-Hong Wei; Fang-Lun Zhou; Yong Li
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.